Skip to content Search the desk⌘ Ctrl K Agent Sign in G GE HealthCare Technologies Inc.
G GEHC GE HealthCare Technologies Inc.
G GEHC GE HealthCare Technologies Inc.
Earnings When GE HealthCare Technologies Inc. reports, what it reported each quarter, and how the stock took the results.
19 quarters. Mar 31, 2022 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
Feb 3, before the open
Wed, Feb 3, 2027 in 76 days
Projected from its last 8 releases. The company has not named the day yet.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Feb 1 – 18 Quarter by quarter 3 years 5 years
Revenue Net income EPS Gross profit Operating income Operating cash flow Free cash flow
Q3 2026 $ 5 . 5 1 B $5.51B +7.2% vs Q3 2025
GE HealthCare Technologies Inc. · CIK 1932393 · Engraved from SEC EDGAR
Jul 29, 2026, before the open
Revenue $5.30B +5.8%
Net income $561.00M +15.4%
EPS $1.24 +17.0%
Revenue $5.13B +7.4%
Net income $389.00M −31.0%
EPS $0.85 −30.9%
Revenue $5.70B +7.1%
Net income $588.00M −18.4%
EPS — —
Results day Typical move ±5.7% A typical move of 5.7% either way
Up after 8 of 12, down after 4.
−3.4% +10.2% +2.4%
When it reports
Usual day Wednesday 7 of its last 8
After quarter end 29 to 35 days
10-Q filed 29 to 30 days over its last 8
10-K filed 35 to 46 days over its last 4 ended Sep 30, 2024 · filed Oct 30, 2024 · 30 d ended Dec 31, 2024 · filed Feb 13, 2025 · 44 d ended Mar 31, 2025 · filed Apr 30, 2025 · 30 d ended Jun 30, 2025 · filed Jul 30, 2025 · 30 d ended Sep 30, 2025 · filed Oct 29, 2025 · 29 d Oct 28, 2026 · pre-market
Q2 2026 Jun 30, 2026 Jul 29, 2026 · pre-market Jul 29, 2026 29 d 10-Q $5.30B +5.8% $1.24 +12.0%
Q1 2026 Mar 31, 2026 Apr 29, 2026 · pre-market Apr 29, 2026 29 d 10-Q $5.13B +7.4% $0.85 13.2%
FY 2025 Q4 2025 derived Dec 31, 2025 Feb 4, 2026 · pre-market Feb 4, 2026 35 d 10-K $5.70B +7.1% — +4.8% Q3 2025 Sep 30, 2025 Oct 29, 2025 · pre-market Oct 29, 2025 29 d 10-Q $5.14B +5.8% $0.98 2.7% Q2 2025 Jun 30, 2025 Jul 30, 2025 · pre-market Jul 30, 2025 30 d 10-Q $5.01B +3.5% $1.06 7.9% Q1 2025 Mar 31, 2025 Apr 30, 2025 · pre-market Apr 30, 2025 30 d 10-Q $4.78B +2.7% $1.23 +3.3%
FY 2024 Q4 2024 derived Dec 31, 2024 Feb 13, 2025 · pre-market Feb 13, 2025 44 d 10-K $5.32B +2.2% — +8.9% Q3 2024 Sep 30, 2024 Oct 30, 2024 · pre-market Oct 30, 2024 30 d 10-Q $4.86B +0.9% $1.02 +2.2% Q2 2024 Jun 30, 2024 Jul 31, 2024 · pre-market Jul 31, 2024 31 d 10-Q $4.84B +0.5% $0.93 +2.4% Q1 2024 Mar 31, 2024 Apr 30, 2024 · pre-market Apr 30, 2024 30 d 10-Q $4.65B −1.2% $0.81 —
FY 2023 Q4 2023 derived Dec 31, 2023 Feb 6, 2024 · pre-market Feb 6, 2024 37 d 10-K $5.21B +5.4% — +10.2% Q3 2023 Sep 30, 2023 Oct 31, 2023 · pre-market Oct 31, 2023 31 d 10-Q $4.82B +5.4% $0.82 — Q2 2023 Jun 30, 2023 Jul 25, 2023 · pre-market Jul 25, 2023 25 d 10-Q $4.82B +7.4% $0.91 3.4% Q1 2023 Mar 31, 2023 Apr 25, 2023 · pre-market Apr 25, 2023 25 d 10-Q $4.71B +8.4% $0.41 8.4%
FY 2022 Q4 2022 derived Dec 31, 2022 Jan 30, 2023 · pre-market Feb 15, 2023 46 d 10-K $4.94B — — +2.0% Q3 2022 Sep 30, 2022 — — — — $4.58B — $1.07 — Q2 2022 Jun 30, 2022 — — — — $4.48B — $1.07 — Q1 2022 Mar 31, 2022 — — — — $4.34B — $0.86 —
Earlier years, FY 2022 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
Apr 29, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $5.70B Revenue, change from a year earlier: Q3 2026 +7.2%, Q2 2026 +5.8%, Q1 2026 +7.4%, Q4 2025 +7.1% +7.1% +7.4% +5.8% +7.2%
Net income $588.00M Net income, change from a year earlier: Q3 2026 +37.9%, Q2 2026 +15.4%, Q1 2026 −31.0%, Q4 2025 −18.4% −18.4% −31.0% +15.4% +37.9%
EPS — EPS, change from a year earlier: Q3 2026 +38.8%, Q2 2026 +17.0%, Q1 2026 −30.9%, Q3 2025 −3.9% −3.9% −30.9% +17.0% +38.8% +6.7% by the close of Oct 28
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
+12.0% by the close of Jul 29
ended Dec 31, 2025 · filed Feb 4, 2026 · 35 d ended Mar 31, 2026 · filed Apr 29, 2026 · 29 d ended Jun 30, 2026 · filed Jul 29, 2026 · 29 d ended Sep 30, 2026 · filed Oct 28, 2026 · 28 d window Feb 1 – 18 · projected The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: −13.2% after Q1 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks